Search for: "C Lillie" Results 1 - 20 of 440
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Apr 2024, 11:33 am by admin
There was a good bit of irony in Egilman’s reaching out to me to help him prepare for my deposition of him in a silicone gel breast implant case. [read post]
24 Apr 2024, 5:59 am by Moll Law Group
Studies demonstrate that rats exposed to Zepbound develop thyroid C-cell tumors, but researchers don’t know whether the drug causes the same tumors in people. [read post]
22 Apr 2024, 5:00 am by Bernard Bell
Many state and local officials host social media sites and use them to converse with followers on matters related to their governmental responsibilities, among other things.[1]  Not surprisingly, many choose to block from their sites certain members of the public they find disagreeable.[2] Being disagreeable, or at least in disagreement with such actions, blocked followers sometimes sue alleging that their exclusion violates the First Amendment.[3]  One of the most notable examples was a… [read post]
19 Apr 2024, 9:27 am by CFM Admin
A qualifying venture capital fund is a venture capital fund which, by virtue of its being under the applicable dollar threshold in aggregate capital contributions and uncalled committed capital, is exempted from the 100 beneficial owner limitation of Section 3(c)(1) of the Investment Company Act of 1940, as amended, and may instead raise capital from up to 250 beneficial owners. [read post]
29 Feb 2024, 5:17 pm by Kurt R. Karst
§ 156(c); and (2) why the PTE application for the ‘929 patent should remain under consideration despite Lilly’s express written request of withdrawal (revocation) of BLA-761038 and waiver of the opportunity for a hearing. [read post]
20 Dec 2023, 5:00 am by Timothy Bonis
Major industry players filed amici briefs on both sides, AbbVie, Bristol Meyers Squibb, and Merck supporting Amgen, and Pfizer, Eli Lilly, Genentech, and AstraZeneca supporting Sanofi. [read post]
14 Nov 2023, 4:18 am by Chloe Dickson (Bristows)
  The judge considered these two differences collectively in determining whether PMI’s product infringed as an equivalent (the approach he endorsed in Regen v Estar[2]) under the 3-step test set out in Actavis v Eli Lilly[3]. [read post]
24 Oct 2023, 4:22 am by Seán Binder
Signup to receive the Early Edition in your inbox here. [read post]
2 Oct 2023, 7:23 am by The Petrie-Flom Center Staff
Dom Kelly is the Co-Founder, President & CEO of New Disabled South, a 501(c)(3) nonprofit organization, and New Disabled South Rising, its 501(c)(4) arm.The post Building a Disability Organization Rooted in Disability Justice first appeared on Bill of Health.The post Building a Disability Organization Rooted in Disability Justice appeared first on Bill of Health. [read post]
2 Aug 2023, 7:00 am by Miquel Montañá (Clifford Chance)
To put in context the points discussed in the judgment, it will be useful to provide some background on the case: Eli Lilly owned a patent that protected the use of raloxifene in the preparation of a medicament useful for the prevention and treatment of osteoporosis. [read post]
20 Jul 2023, 10:44 am by Marcia Delgadillo
First, we welcome back Lilly Palmer as a Partner, whose extensive digital asset experience will benefit the firm and all its clients. [read post]
27 Apr 2023, 9:22 am by Miquel Montañá (Clifford Chance)
In this regard, in its judgment of 12 December 2013 (case C-493/12, Eli Lilly v Human Genome Sciences), the CJEU made the following observations: “30. [read post]
3 Mar 2023, 12:01 am by Gene Takagi
Today, Eli Lilly did that,” Biden said in a statement. [read post]
10 Feb 2023, 4:44 am by admin
Putting aside the idiosyncratic chapter by the late Professor Berger, most of the third edition of the Reference Manual presented guidance on many important issues. [read post]